We are live on
!
Find out more
TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.7B
1-Year Est. Return
6.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$7.3B
AUM Growth
+$297M
(+4.2%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
17.43%
Holding
817
New
58
Increased
143
Reduced
218
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$86.7M |
| 2 |
Graphic Packaging
GPK
|
+$49.8M |
| 3 |
Flex
FLEX
|
+$46.9M |
| 4 |
Old Republic International
ORI
|
+$46M |
| 5 |
NVR
NVR
|
+$40.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$92.1M |
| 2 |
Bunge Global
BG
|
+$50.3M |
| 3 |
Leidos
LDOS
|
+$39.3M |
| 4 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$38.5M |
| 5 |
NCR Voyix
VYX
|
+$34.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.68% |
| 2 | Technology | 12.23% |
| 3 | Healthcare | 9.96% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Utilities | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
PPG Industries
PPG
$24.6B
| $78K | ﹤0.01% |
460
-5
| -1% | -$858 |
|
452
Sarepta Therapeutics
SRPT
$1.57B
| $78K | ﹤0.01% |
1,000
| – | – |
|
453
Enterprise Products Partners
EPD
$82.3B
| $77K | ﹤0.01% |
3,200
| – | – |
|
454
Morningstar
MORN
$7.22B
| $77K | ﹤0.01% |
300
| – | – |
|
455
Goldman Sachs
GS
$300B
| $76K | ﹤0.01% |
199
-10
| -5% | -$3.58K |
|
456
Medtronic
MDT
$109B
| $75K | ﹤0.01% |
601
-256
| -30% | -$32.1K |
|
457
Wabtec
WAB
$49.1B
| $75K | ﹤0.01% |
907
-7
| -0.8% | -$568 |
|
|
MRC
458
DELISTED
MRC Global
MRC
| $73K | ﹤0.01% |
7,775
| – | – |
|
459
Avis
CAR
$4.86B
| $72K | ﹤0.01% |
920
| – | – |
|
460
Consolidated Edison
ED
$40.1B
| $72K | ﹤0.01% |
1,000
| – | – |
|
461
WEC Energy
WEC
$35.7B
| $71K | ﹤0.01% |
800
-115
| -13% | -$10.8K |
|
462
Bank Of The James
BOTJ
$123M
| $70K | ﹤0.01% |
4,400
| – | – |
|
463
NetEase
NTES
$85.3B
| $69K | ﹤0.01% |
600
| – | – |
|
464
BorgWarner
BWA
$13.1B
| $68K | ﹤0.01% |
1,598
-740,714
| -100% | -$32.6M |
|
465
US Bancorp
USB
$98.2B
| $68K | ﹤0.01% |
1,200
-9
| -0.7% | -$528 |
|
466
Mativ Holdings
MATV
$481M
| $67K | ﹤0.01% |
1,670
| – | – |
|
467
Camden Property Trust
CPT
$11B
| $66K | ﹤0.01% |
500
| – | – |
|
468
Pitney Bowes
PBI
$2.4B
| $66K | ﹤0.01% |
7,500
| – | – |
|
469
Vanguard S&P 500 Growth ETF
VOOG
$25.9B
| $66K | ﹤0.01% |
1,500
| – | – |
|
470
Xcel Energy
XEL
$48.8B
| $65K | ﹤0.01% |
993
-125
| -11% | -$8.7K |
|
471
Fortive
FTV
$17.9B
| $64K | ﹤0.01% |
1,210
| – | – |
|
472
FirstEnergy
FE
$28B
| $63K | ﹤0.01% |
1,693
+931
| +122% | +$34.6K |
|
473
Air Products & Chemicals
APD
$65.7B
| $60K | ﹤0.01% |
209
| – | – |
|
474
Coca-Cola Consolidated
COKE
$12.5B
| $60K | ﹤0.01% |
1,500
| – | – |
|
475
Ingevity
NGVT
$2.51B
| $60K | ﹤0.01% |
734
| – | – |
|
Similar funds
PI
ACM
VH
O
XT
DCP
HW
AAM
Thompson Siegel & Walmsley's Q2 2021 Portfolio in Review
As of Q2 2021, Thompson Siegel & Walmsley held 817 positions worth $7.3B, up 4.2% from $7.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Thompson Siegel & Walmsley's Q2 2021 filing shows 58 new, 143 increased, 218 reduced and 72 closed positions. Its largest new stake was Organon & Co: 2,634,306 shares worth $79.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Thompson Siegel & Walmsley's largest Q2 2021 buy was Organon & Co: 2,634,306 shares worth $79.7M.
- Thompson Siegel & Walmsley added most to Graphic Packaging in Q2 2021, an estimated $49.8M increase.
- Thompson Siegel & Walmsley's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $92.1M.
- Thompson Siegel & Walmsley fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $38.5M.
- Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $7.3B portfolio in Q2 2021.
- Thompson Siegel & Walmsley opened 58 new positions and closed 72 in Q2 2021.
- Thompson Siegel & Walmsley's portfolio value rose 4.2% quarter-over-quarter to $7.3B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.